“Chronic irritable itch” is defined as a constant itchy sensation that’s difficult to treat, and is a common medical condition among dialysis patients. A study from the Florida campus of the Scripps Research Institute focused on a medication that could treat the condition without the adverse side effects normally associated with medicating the condition. Researchers tested the compound, a combination of opioids and other chemicals, on mouse models to determine effectiveness. The drug compounds target receptors in the central nervous system that moderate pain perception and stress responses. It was found that the combination was successful in stopping the itch [...]

Nearly 8 percent of ESRD patients have Hepatitis C. Medications like Sovaldi have offered a chance to cure Hepatitis C, but are unavailable to ESRD patients due to chemical contents. However, a recent new drug combination has shown potential in curing the Hepatitis C virus in ESRD patients. The drug combination, developed by Merck, was the focus of a recent study involving 224 ESRD patients. The participants were divided into two groups; 116 took a single pill with the two drugs for 12 weeks, while the rest received the placebo. Results showed that 99 percent of the group who took the real [...]